These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 166832)

  • 1. Binding of glycyrrhetinic acid to kidney mineralocorticoid and glucocorticoid receptors.
    Ulmann A; Menard J; Corvol P
    Endocrinology; 1975 Jul; 97(1):46-51. PubMed ID: 166832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RU-26988--a new tool for the study of the mineralocorticoid receptor.
    Gomez-Sanchez CE; Gomez-Sanchez EP
    Endocrinology; 1983 Sep; 113(3):1004-9. PubMed ID: 6307658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal receptor-binding activity of reduced metabolites of aldosterone: evidence for a mineralocorticoid effect outside of the classic aldosterone receptor system.
    Gomez-Sanchez CE; Smith JS; Ferris MW; Gomez-Sanchez EP
    Endocrinology; 1984 Aug; 115(2):712-5. PubMed ID: 6086276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of rat brain aldosterone receptors reveals high affinity for corticosterone.
    Beaumont K; Fanestil DD
    Endocrinology; 1983 Dec; 113(6):2043-51. PubMed ID: 6227474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mineralocorticoid and renal receptor binding activity of 21-deoxyaldosterone.
    Koshida H; Miyamori I; Soma R; Matsubara T; Ikeda M; Takeda R; Nakamura S; Kiuchi F; Tsuda Y
    Endocrinology; 1990 Mar; 126(3):1410-5. PubMed ID: 2155101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Licorice inhibits 11 beta-hydroxysteroid dehydrogenase messenger ribonucleic acid levels and potentiates glucocorticoid hormone action.
    Whorwood CB; Sheppard MC; Stewart PM
    Endocrinology; 1993 Jun; 132(6):2287-92. PubMed ID: 8504732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of mineralocorticoid binding sites in rat brain by competition studies and density gradient centrifugation.
    Coirini H; Marusic ET; De Nicola AF; Rainbow TC; McEwen BS
    Neuroendocrinology; 1983 Nov; 37(5):354-60. PubMed ID: 6316188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Equivalent affinity of aldosterone and corticosterone for type I receptors in kidney and hippocampus: direct binding studies.
    Sheppard KE; Funder JW
    J Steroid Biochem; 1987 Dec; 28(6):737-42. PubMed ID: 2826920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 16Beta-hydroxydehydroepiandrosterone: the dichotomy between renal receptor binding and urinary electrolyte activity.
    Funder JW; Robinson JA; Feldman D; Wynne KN; Adam WR
    Endocrinology; 1976 Aug; 99(2):619-28. PubMed ID: 182463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal mineralocorticoid receptors and hippocampal corticosterone-binding species have identical intrinsic steroid specificity.
    Krozowski ZS; Funder JW
    Proc Natl Acad Sci U S A; 1983 Oct; 80(19):6056-60. PubMed ID: 6310613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of action of a new antialdosterone compound, prorenone.
    Claire M; Rafestin-Oblin ME; Michaud A; Roth-Meyer C; Corvol P
    Endocrinology; 1979 Apr; 104(4):1194-200. PubMed ID: 436757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is the renal type III corticosteroid-binding site the collecting duct-specific isoform of 11 beta-hydroxysteroid dehydrogenase?
    Náray-Fejes-Tóth A; Rusvai E; Fejes-Tóth G
    Endocrinology; 1994 Apr; 134(4):1671-5. PubMed ID: 8137730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrinsic mineralocorticoid agonist activity of some nonsteroidal anti-inflammatory drugs. A postulated mechanism for sodium retention.
    Feldman D; Couropmitree C
    J Clin Invest; 1976 Jan; 57(1):1-7. PubMed ID: 173739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mineralocorticoid receptors in human kidney.
    Matulich DT; Spindler BJ; Schambelan M; Baxter JD
    J Clin Endocrinol Metab; 1976 Nov; 43(5):1170-4. PubMed ID: 993320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mineralocorticoid effector mechanism of liquorice derivatives in human mononuclear leukocytes.
    Armanini D; Wehling M; Weber PC
    J Endocrinol Invest; 1989 May; 12(5):303-6. PubMed ID: 2549114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptor binding and biological activity of 18-oxocortisol.
    Gomez-Sanchez CE; Gomez-Sanchez EP; Smith JS; Ferris MW; Foecking MF
    Endocrinology; 1985 Jan; 116(1):6-10. PubMed ID: 2856875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycyrrhizic acid and its hydrolysate as mineralocorticoid agonist.
    Takeda R; Miyamori I; Soma R; Matsubara T; Ikeda M
    J Steroid Biochem; 1987; 27(4-6):845-9. PubMed ID: 2826910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on arterial mineralocorticoid and glucocorticoid receptors: evidence for the translocation of steroid-cytoplasmic receptor complexes to cell nuclei.
    Kornel L; Kanamarlapudi N; Ramsay C; Taff DJ
    Clin Physiol Biochem; 1984; 2(1):14-31. PubMed ID: 6091978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The binding of 18-hydroxydeoxycorticosterone and 18-hydroxycorticosterone to mineralocorticoid and glucocorticoid receptors in the rat kidney.
    Feldman D; Funder JW
    Endocrinology; 1973 May; 92(5):1389-96. PubMed ID: 4348649
    [No Abstract]   [Full Text] [Related]  

  • 20. Demonstration of specific high affinity receptors for aldosterone in cytosol of rat colon.
    Binder HJ; White A; Whiting D; Hayslett J
    Endocrinology; 1986 Feb; 118(2):628-31. PubMed ID: 2935388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.